Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
If you have cash to spare, these cancer stocks are set to soar.
Some investors think the market's been too hard on these drugmakers.
GTHX earnings call for the period ending June 30, 2022.
GTHX earnings call for the period ending December 31, 2021.
GTHX earnings call for the period ending September 30, 2021.
GTHX earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.